1.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALK-01-017, DFCI-95066, NCI-V95-0789
|
|
2.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: YALE-HIC-8729, NCI-V96-0884
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-98-C-0074H, CCG-09716, ALK-01-041, NCI-T98-0011, COG-C09716, T98-0011, NCT00019422
|
|
4.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: ALK-01-036, NCI-96-C-0068C
|
|
5.
|
Phase: Phase I
Type: Treatment
Status: Temporarily closed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: COG-ADVL0012, CCG-ADVL0012, ALK-01-042, CCG-09802, NCT00005602, ADVL00012
|
Mobile | Español
